Zymeworks
Computational biotechnology company that is focused on optimizing therapeutic antibodies and other protein-based therapeutics. Learn more
Launch date
Employees
Market cap
€810m
Enterprise valuation
€528m (Public information from Sep 2024)
Share price
$13.05 ZYME
Vancouver British Columbia (HQ)
Authorizing premium user...